Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.

Reis, Ben Y; Barda, Noam; Leshchinsky, Michael; Kepten, Eldad; Hernán, Miguel A; Lipsitch, Marc; Dagan, Noa; Balicer, Ran D

Reis, Ben Y; Barda, Noam; Leshchinsky, Michael; Kepten, Eldad; Hernán, Miguel A; Lipsitch, Marc; Dagan, Noa; Balicer, Ran D.

Reis BY; Boston Children's Hospital, Boston, MA.
Barda N; Clalit Research Institute, Tel Aviv, Israel.
Leshchinsky M; Clalit Research Institute, Tel Aviv, Israel.
Kepten E; Clalit Research Institute, Tel Aviv, Israel.
Hernán MA; Harvard T.H. Chan School of Public Health, Boston, MA.
Lipsitch M; Harvard T.H. Chan School of Public Health, Boston, MA.
Dagan N; Clalit Research Institute, Tel Aviv, Israel rbalicer@clalit.org.il.
Balicer RD; Clalit Research Institute, Tel Aviv, Israel rbalicer@clalit.org.il.

N Engl J Med ; 385(22): 2101-2103, 2021 11 25.

Article in English | MEDLINE | ID: covidwho-1473548

Subject(s)

BNT162 Vaccine; COVID-19/prevention & control; SARS-CoV-2; Vaccine Efficacy/statistics & numerical data; Adolescent; Child; Humans; Israel

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Vaccine Efficacy / BNT162 Vaccine Type of study: Experimental Studies Topics: Vaccines / Variants Limits: Adolescent / Child / Humans Country/Region as subject: Asia Language: English Journal: N Engl J Med Year: 2021 Document Type: Article Affiliation country: NEJMc2114290

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google